Gastroesophageal Reflux Disease as an Indication of Revisional Bariatric Surgery-Indication and Results-a Systematic Review and Metanalysis.
Sonja ChiappettaPanagiotis LainasRadwan KassirRohollah ValizadehAlfonso BoscoMohammad KermansaraviPublished in: Obesity surgery (2022)
This systematic review evaluates the indications and results of revisional bariatric surgery (RBS) in gastroesophageal reflux disease (GERD). A systematic literature search and meta-analysis was performed for articles published by April 1, 2021. After examining 722 papers involving 17,437 patients, 48 studies were included (n = 915 patients). RBS for GERD was mostly reported after sleeve gastrectomy (n = 796, 87%) and one anastomosis gastric bypass (n = 62, 6.8%) and was performed due to intractable GERD (71.6%), GERD and weight issues (16%), and biliary reflux (6.2%). Mean follow-up of the studies was 31.5 (3-84) months. Pooled estimation of a meta-analysis of studies reported 7% of GERD following primary surgery needing RBS, in which 99% of the patients experienced remission.
Keyphrases
- gastroesophageal reflux disease
- systematic review
- end stage renal disease
- bariatric surgery
- gastric bypass
- newly diagnosed
- ejection fraction
- chronic kidney disease
- randomized controlled trial
- body mass index
- minimally invasive
- obese patients
- patient reported outcomes
- rheumatoid arthritis
- clinical trial
- acute coronary syndrome
- systemic lupus erythematosus
- meta analyses
- patient reported
- disease activity